| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,790 |
8,452 |
$761K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,044 |
2,876 |
$228K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,864 |
1,505 |
$133K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
710 |
662 |
$84K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,325 |
1,222 |
$55K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
601 |
571 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,025 |
1,745 |
$24K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
501 |
463 |
$7K |
| 99051 |
|
1,593 |
1,324 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
878 |
805 |
$3K |
| 81002 |
|
987 |
837 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
41 |
39 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
55 |
40 |
$904.58 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
68 |
31 |
$892.84 |
| 36415 |
Collection of venous blood by venipuncture |
274 |
252 |
$617.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$177.15 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
13 |
$105.36 |